Syntekabio, Foreign Investors Net Buy 3,000 Shares... Stock Price Up 18.77%
Syntheca Bio has ranked among the top searched stocks on 9 days within the past month.
As of 12:35 PM on the 5th, Syntheca Bio is trading at 46,200 KRW, up 18.77% from the previous day. This marks a 218.62% increase compared to September 2. Syntheca Bio is known as a genomic big data research company.
Today, foreign investors are tentatively recorded as net buyers of 3,000 shares. Over the past 5 days, individual investors have net purchased 57,640 shares, while foreign and institutional investors have net sold 59,425 shares and net bought 2,690 shares, respectively.
On September 29, Syntheca Bio became a market issue with the headline "COVID-19 treatment efficacy Remdesivir doubled, hitting the upper price limit."
Hot Picks Today
!["Even If I Lose My Investment, the Government Will Cover It"... The Fund Attracting Retail Investors' Attention [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051609052165501_1778889921.jpg)
"Even If I Lose My Investment, the Government Will Cover It"... The Fund Attracting Retail Investors' Attention [Weekend Money]
- AI Said to Eliminate Jobs, but This Role Sees 800% Surge in Hiring [Tech Talk]
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
